MYRIAD GENETICS INC — DEF 14A

MYRIAD GENETICS INC of SALT LAKE CITY, UT filed a DEF 14A with the SEC on 2026-04-14. Industry: In Vitro & In Vivo Diagnostic Substances.

Filing

Documents (70)

Showing 15 of 70 documents.

SeqTypeDescription
1DEF 14ADEF 14A
2EX-101.SCHXBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
3EX-101.DEFXBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
4EX-101.LABXBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
5EX-101.PREXBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
6GRAPHICmygn-20260414_g1.jpg
7GRAPHICmygn-20260414_g10.jpg
8GRAPHICmygn-20260414_g11.jpg
9GRAPHICmygn-20260414_g12.jpg
10GRAPHICmygn-20260414_g13.jpg
11GRAPHICmygn-20260414_g14.jpg
12GRAPHICmygn-20260414_g15.jpg
13GRAPHICmygn-20260414_g16.jpg
14GRAPHICmygn-20260414_g17.jpg
15GRAPHICmygn-20260414_g18.jpg

Filing timeline for this registrant (60)

Showing 12 of 60 filings.

FiledForm
2026-04-14DEFA14A
2026-04-14DEF 14A
2025-04-09DEFA14A
2025-04-09DEF 14A
2024-04-17DEFA14A
2024-04-17DEF 14A
2023-04-12DEFA14A
2023-04-12DEF 14A
2023-03-30PRE 14A
2022-04-14DEFA14A
2022-04-14DEF 14A
2021-04-15DEFA14A

More